🇺🇸 Beclometasone/Formoterol in United States
118 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 118
Most-reported reactions
- Dyspnoea — 34 reports (28.81%)
- Fall — 15 reports (12.71%)
- Cough — 9 reports (7.63%)
- General Physical Health Deterioration — 9 reports (7.63%)
- Headache — 9 reports (7.63%)
- Pain — 9 reports (7.63%)
- Pyrexia — 9 reports (7.63%)
- Acute Kidney Injury — 8 reports (6.78%)
- Anaemia — 8 reports (6.78%)
- Dizziness — 8 reports (6.78%)
Other Respiratory/Pulmonology approved in United States
Frequently asked questions
Is Beclometasone/Formoterol approved in United States?
Beclometasone/Formoterol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Beclometasone/Formoterol in United States?
Chiesi Farmaceutici S.p.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.